button bars forest bayes pooled summary circles
 
deaths (OS)progression or deaths (PFS)RFS/DFS

mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - all population

versus docetaxel
atezolizumab alone vs. docetaxel 2 1.0better0.35.0100 %1.0better0.35.079 %-
avelumab alone vs. docetaxel 1 1.0better0.35.087 %1.0better0.35.094 %-
nivolumab alone vs. docetaxel 1 1.0better0.35.0100 %1.0better0.35.099 %-
Tislelizumab vs. docetaxel 1 ---

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons